Mark E. Strome 13D and 13G filings for Cue Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-16 4:01 pm Purchase |
2022-11-14 | 13G | Cue Biopharma, Inc. CUE |
Mark E. Strome | 2,166,242 4.990% |
1,375,630 (+174.00%) |
Filing |